| Literature DB >> 25389133 |
Pierre-Jacques Brun1, Ambar Grijalva1, Richard Rausch1, Elizabeth Watson1, Jason J Yuen1, Bhaskar C Das1, Koichi Shudo1, Hiroyuki Kagechika1, Rudolph L Leibel1, William S Blaner2.
Abstract
Retinoic acid signaling is required for maintaining a range of cellular processes, including cell differentiation, proliferation, and apoptosis. We investigated the actions of all-trans-retinoic acid (atRA) signaling in pancreatic β-cells of adult mice. atRA signaling was ablated in β-cells by overexpressing a dominant-negative retinoic acid receptor (RAR)-α mutant (RARdn) using an inducible Cre-Lox system under the control of the pancreas duodenal homeobox gene promoter. Our studies establish that hypomorphism for RAR in β-cells leads to an age-dependent decrease in plasma insulin in the fed state and in response to a glucose challenge. Glucose-stimulated insulin secretion was also impaired in islets isolated from mice expressing RARdn. Among genes that are atRA responsive, Glut2 and Gck mRNA levels were decreased in isolated islets from RARdn-expressing mice. Histologic analyses of RARdn-expressing pancreata revealed a decrease in β-cell mass and insulin per β-cell 1 mo after induction of the RARdn. Our results indicate that atRA signaling mediated by RARs is required in the adult pancreas for maintaining both β-cell function and mass, and provide insights into molecular mechanisms underlying these actions. © FASEB.Entities:
Keywords: Cre recombinase; dominant-negative RAR; glucagon; pancreatic islet; retinoid
Mesh:
Substances:
Year: 2014 PMID: 25389133 PMCID: PMC4314234 DOI: 10.1096/fj.14-256743
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191